RNA polymerase II stalling promotes nucleosome occlusion and pTEFb recruitment to drive immortalization by Epstein-Barr virus.
about
P-TEFb goes viralOpen access chemical probes for epigenetic targetsProtein lysine acetylation by p300/CBPInhibition of BET bromodomains as a therapeutic strategy for cancer drug discoveryBET domain co-regulators in obesity, inflammation and cancerEpigenetic regulation of EBV persistence and oncogenesis.Chemical probes targeting epigenetic proteins: Applications beyond oncology.Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming.Inhibition of cdk9 during herpes simplex virus 1 infection impedes viral transcriptionThe Epstein-Barr virus BamHI C promoter is not essential for B cell immortalization in vitro, but it greatly enhances B cell growth transformation.Ser-634 and Ser-636 of Kaposi's Sarcoma-Associated Herpesvirus RTA are Involved in Transactivation and are Potential Cdk9 Phosphorylation Sites.Papillomavirus-Associated Tumor Formation Critically Depends on c-Fos Expression Induced by Viral Protein E2 and Bromodomain Protein Brd4.Repression of Hox genes by LMP1 in nasopharyngeal carcinoma and modulation of glycolytic pathway genes by HoxC8.Infection by Herpes Simplex Virus 1 Causes Near-Complete Loss of RNA Polymerase II Occupancy on the Host Cell GenomeDynamic changes of the epigenetic landscape during cellular differentiation.Bromodomain and extraterminal inhibitors block the Epstein-Barr virus lytic cycle at two distinct steps.Therapeutics Targeting Protein Acetylation Perturb Latency of Human Viruses.RUNX super-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growth.P-TEFb goes viral.A single amino acid in EBNA-2 determines superior B lymphoblastoid cell line growth maintenance by Epstein-Barr virus type 1 EBNA-2.Negative elongation factor-mediated suppression of RNA polymerase II elongation of Kaposi's sarcoma-associated herpesvirus lytic gene expression.Downregulation of integrin receptor-signaling genes by Epstein-Barr virus EBNA 3C via promoter-proximal and -distal binding elementsA Novel Bromodomain Inhibitor Reverses HIV-1 Latency through Specific Binding with BRD4 to Promote Tat and P-TEFb Association.Regulation of the human papillomavirus type 16 late promoter by transcriptional elongation.Dynamic chromatin environment of key lytic cycle regulatory regions of the Epstein-Barr virus genome.Early gene expression changes by Epstein-Barr virus infection of B-cells indicate CDKs and survivin as therapeutic targets for post-transplant lymphoproliferative diseases.Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome.BET bromodomain inhibitors show anti-papillomavirus activity in vitro and block CRPV wart growth in vivo.
P2860
Q26741360-8D537081-F6BD-4147-B941-BA7157DD3695Q26781872-846AEF4F-69A2-4D32-A8F3-D57D84AAAC14Q27021749-DE40D800-0F96-49BF-A594-2A33D03E524DQ28260105-2E8D6FD3-9B01-4356-A641-30B03A8F4401Q28269301-08FB145C-974D-404B-ABA9-D6A31609AA1FQ33723664-9B9464BE-DB97-4BD5-B4AC-52DCD68294A6Q33751386-6418394D-83CC-4A73-BE46-382C8AD40A63Q34998243-D4D513D0-7A3D-4C39-9AF4-2616F548F1FBQ35036881-A57631F0-7BF2-4EC9-912F-C0AE7BC8E115Q35076676-919CC0E2-9C81-4862-88BA-2FF2FC7CAA3FQ35770298-49BF9858-2910-4CA7-8BDB-A0F6D70F95EBQ35884158-46F1A1C7-9A17-42CF-A82A-A0A69E54870CQ36042582-4F7E9AA7-79BA-46EA-9073-F1AC4260EF29Q36736766-9E672893-CA57-4FCF-9C3F-70E49316C1BCQ38166840-A6F4EEA1-8132-4321-A40E-E0CA6F27368AQ38701064-C7729C3E-074D-4744-A04D-4536F4F7123BQ38723116-C53BA58F-E71C-499D-A879-8EADF3561B12Q38793717-4D8159A4-2629-4F39-AFB7-770AE9BB44E1Q38896947-F5D95EDA-A475-4933-B722-E4D9AD17BF63Q38992835-7B773AC5-A3B2-4DE7-860A-7CDFCF1E321FQ39323907-8703DDC3-A1BA-43B6-AD2F-708D9C5316EBQ39392125-24E418EB-3064-4C1C-B876-68824B474234Q40150438-F9310C0D-04C9-45D0-AD18-D1500EDB3B5AQ40225247-FD534284-66E7-444B-B7AA-67E0F13B6C90Q40605557-84F61CEE-0A6F-4B27-8632-C5B55F56B91FQ42264347-C454561B-08B4-4CFB-8E2E-2E0C7A41AF05Q50535712-2A3878BB-ABA7-49A4-9372-5D7DDC5CCC41Q52589764-FAF53DE1-2067-4523-9C95-3FF2C0C29D24
P2860
RNA polymerase II stalling promotes nucleosome occlusion and pTEFb recruitment to drive immortalization by Epstein-Barr virus.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
RNA polymerase II stalling pro ...... ization by Epstein-Barr virus.
@ast
RNA polymerase II stalling pro ...... ization by Epstein-Barr virus.
@en
RNA polymerase II stalling pro ...... ization by Epstein-Barr virus.
@nl
type
label
RNA polymerase II stalling pro ...... ization by Epstein-Barr virus.
@ast
RNA polymerase II stalling pro ...... ization by Epstein-Barr virus.
@en
RNA polymerase II stalling pro ...... ization by Epstein-Barr virus.
@nl
prefLabel
RNA polymerase II stalling pro ...... ization by Epstein-Barr virus.
@ast
RNA polymerase II stalling pro ...... ization by Epstein-Barr virus.
@en
RNA polymerase II stalling pro ...... ization by Epstein-Barr virus.
@nl
P2093
P2860
P1433
P1476
RNA polymerase II stalling pro ...... ization by Epstein-Barr virus.
@en
P2093
Helen M Webb
Michelle J West
Richard D Palermo
P2860
P304
P356
10.1371/JOURNAL.PPAT.1002334
P577
2011-10-27T00:00:00Z